THIS FALL, THE FDA ANNOUNCES THAT IT WILL ONLY APPROVE SHOTS FOR SPECIFIC HIGH RISK GROUPS, AND THOSE INCLUDE. YOU’RE FAMILIAR WITH IT, RIGHT? ADULTS OVER THE AGE OF 65 AND PEOPLE WITH CERTAIN ...

The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing "the need for evidence" of their effectiveness. "We simply don’t know whether a ...

But there's no denying that it's seen a surge of interest in recent years. Ketamine clinics—or treatment centers that offer infusions of the drug—have popped up all over the country, not to mention on ...

An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...

This latest drug is among *** new group showing promise. The FDA granted accelerated approval for another experimental Alzheimer's drug called Lean IAB in January, Robert Eggy with the Alzheimer's ...

The FDA announced this week it’s ramping up its review of food additives — with azodicarbonamide (ADA), the so-called “yoga mat chemical” used in some breads and baked goods, among those ...

More recently, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the use of the enantiomer esketamine, based on results of different phase III ...

The test, called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is for adults 55 and older who are showing signs and symptoms of Alzheimer’s disease, the FDA announced Friday. It works by ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Adam Feuerstein is ...